Prolia (Denosumab) Cancer Risk Signal Review: What Women Need to Know
A plain-language review of the cancer risk signal linked to denosumab (Prolia) for women with osteoporosis, covering trial data, FDA signals, and life-stage guidance.
Read clinical review